X4 Pharmaceuticals (XFOR) Change in Acquisitions & Divestments (2023 - 2025)

X4 Pharmaceuticals has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $18.8 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 32.04% year-over-year to $18.8 million; the trailing twelve-month figure through Dec 2025 stood at $74.5 million (up 181.82% YoY), and the FY2025 full-year result was $74.5 million, up 181.82% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at $18.8 million, up from $15.9 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $28.2 million in Q2 2025, with the low at $1.0 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $10.3 million across 3 years, with a median of $8.5 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 1320.0% — and 2025, when it soared 32.04%.
• X4 Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.0 million in 2023, then jumped by 1320.0% to $14.2 million in 2024, then jumped by 32.04% to $18.8 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $18.8 million (Q4 2025), $15.9 million (Q3 2025), and $28.2 million (Q2 2025), per Business Quant data.